Volume 32, Number 10—October 2026
Dispatch
Chlamydia psittaci Meningitis, Chile, 2023
Table
Molecular and serologic diagnostic testing results for a study of Chlamydia psittaci meningitis, Chile, 2023*
| Pathogen | Specimen | Method | Target or antibody | Result |
|---|---|---|---|---|
| Parvovirus B19 | CSF | qPCR | NS1, VP1 | Negative |
| Multiplex meningitis/encephalitis panel† | CSF | Real-time multiplex PCR assay | Pathogen-specific nucleic acid targets | Negative |
| Brucella spp. | CSF | qPCR | bcsp31, IS711 | Negative |
| Leptospira spp. | CSF | qPCR | lipL32 or 16S; specify | Negative |
| Chlamydia psittaci | CSF | qPCR | IncA and CPSIT_0607 | Positive |
| Toxoplasma gondii | CSF | qPCR | B1, REP-529 | Negative |
| Coxiella burnetii | Serum | Serology IFA | Phase I and II for IgG, IgM | Negative |
| Brucella spp. | Serum | Serology ELISA | Rose Bengal, SAT, ELISA; specify | Negative |
| Leptospira spp. | Serum | Serology ELISA | IgM | Negative |
| C. psittaci | Serum | Serology IFA | IgG, IgM | Positive IgM and IgG |
*Testing performed on CSF and serum samples for routine and zoonotic pathogens. B1, 35-fold repetitive B1 gene of Toxoplasma gondii; bcsp31, 31 kDa Brucella immunogenic protein gene; CPSIT_0607, DNA sequence gene to C. psittaci hypothetical protein; CSF, cerebral spinal fluid; IFA, indirect immunofluorescence assay; IncA, inclusion membrane protein A; IS711, insertion sequence 711 of Brucella genus; lipL32, recombinant leptospiral outer membrane protein gene; NS1, nonstructural protein 1; qPCR, quantitative PCR; REP-529, noncoding 529-bp DNA fragment that is repeated 200–300 times; SAT, standard agglutination test; VP1, viral protein 1. †Allplex Meningitis-V1 and Meningitis-V2 Assays (Seegene Inc., https://www.seegene.com).